- A highly effective treatment for deep hemangiomas and arteriovenous malformations with intralesional laser treatment2015 | First Faculty of Medicine
- Multiple sclerosis patient suitable for the treatment with ofatumumab2022 | Faculty of Medicine in Hradec Králové
- Ofatumumab - a highly effective therapy for relapsing-remitting multiple sclerosis available in the first line2022 | Faculty of Medicine in Hradec Králové
- Trastuzumab-induced cardiotoxicity: a review2023 | Third Faculty of Medicine
- Testing of NTRK gene fusions - new guidelines for clinical practice in the Czech Republic2020 | First Faculty of Medicine
- Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses2017 | First Faculty of Medicine
- Bone health in breast cancer patients: A comprehensive statement by CECOG/SAKK Intergroup2014 | Publication without faculty affiliation
- Ofatumumab - new and different monoclonal anti-CD20 antibody in the treatment of multiple sclerosis2021 | Second Faculty of Medicine
- Ultrabrief Electroconvulsive Therapy Effectiveness In Treatment Of Depressive Disorder In Adults2011 | Faculty of Medicine in Hradec Králové
- Electroconvulsive Therapy - theory and practice2019 | First Faculty of Medicine
- Ocrelizumab - long-term efficacy and safety in real-world clinical practice in patients with relapsing-remitting multiple sclerosis2022 | Second Faculty of Medicine
- Utility of Hounsfield units in predicting fusion rates of patients undergoing anterior odontoid screw fixation following Anderson d’Alonzo type II and shallow type III fractures2023 | Central Library of Charles University
- Efficacy of the first and subsequent treatment lines with adalimumab in patients with rheumatoid arthritis: data analysis from the Czech National Registry ATTRA2016 | Publication without faculty affiliation
- Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Regimen in the Treatment of Genotype 1 Chronic Hepatitis C Infection in Patients with Severe Renal Impairment and End-Stage Renal Disease: a Real-Life Cohort2018 | First Faculty of Medicine